A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
NCT06308198
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
161
Enrollment
INDUSTRY
Sponsor class
Conditions
Glabellar Lines
Interventions
DRUG:
AGN-151586
DRUG:
Placebo
Sponsor
AbbVie